// company-profile

Tarsus Pharmaceuticals, Inc.

TARS
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings154Insiders17
// api This Tarsus Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 14 insiders purchased shares versus 1 sale. Buying was led by Farrow Jeffrey S.

// 90-day insight

Over the last 90 days, Tarsus Pharmaceuticals, Inc. insiders bought $0 (16 transactions) and sold $877K (1 transaction).

  • Most active insider: LINK WILLIAM J PHD with 4 transactions totaling $776K.
  • Largest single sale: $877K by Farrow Jeffrey S on Jun 16, 2026.
  • 83% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Tarsus Pharmaceuticals, Inc. as of 2026-03-31

— stable
Total reported AUM
$3.06B
QoQ change
-4.1%
Reporting period
2026-03-31
#1
Deep Track Capital, LP
CIK 1856083
$252.5M
3.6M shares
#2
RTW INVESTMENTS, LP
CIK 1493215
$234.7M
3.3M shares
#3
Paradigm Biocapital Advisors LP
CIK 1855655
$179.7M
2.6M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 17, 2026Azamian Bobak R.TARS
Sale10b5
5,418$61.81$335K
Jun 17, 2026Azamian Bobak R.TARS
Sale10b5
4,582$61.24$281K
Jun 16, 2026Farrow Jeffrey STARS
Sale
14,396$60.95$877K
Jun 15, 2026LINK WILLIAM J PHDTARS
Sale10b5
1,928$62.94$121K
Jun 15, 2026Farrow Jeffrey STARS
Option Exercise
27,881

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.